2017
DOI: 10.31768/2312-8852.2017.39(3):171-180
|View full text |Cite
|
Sign up to set email alerts
|

Large-Scale Expansion and Characterization of Human Adult Neural Crest-Derived Multipotent Stem Cells From Hair Follicle for Regenerative Medicine Applications

Abstract: Aim: The purpose of this work was to obtain, multiply and characterize the adult neural crest-derived multipotent stem cells from human hair follicle for their further clinical use. Materials and Methods: Adult neural crest-derived multipotent stem cells were obtained from human hair follicle by explant method and were expanded at large-scale up to a clinically significant number. The resulted cell cultures were examined by flow cytometry and immunocytochemical analysis. Their clonogenic potential, ability to … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
10
0

Year Published

2018
2018
2024
2024

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 9 publications
(10 citation statements)
references
References 22 publications
0
10
0
Order By: Relevance
“…The cultures of HF NCSCs were obtained according to explant method by Sieber-Blum et al [8] in our modification for human samples [45]. Briefly, two skin specimens per donor were excised from the scalp zone under local anesthesia by dermal punch knife (Dermo-Punch ø 4 mm, Sterilab, Italy).…”
Section: Methodsmentioning
confidence: 99%
See 4 more Smart Citations
“…The cultures of HF NCSCs were obtained according to explant method by Sieber-Blum et al [8] in our modification for human samples [45]. Briefly, two skin specimens per donor were excised from the scalp zone under local anesthesia by dermal punch knife (Dermo-Punch ø 4 mm, Sterilab, Italy).…”
Section: Methodsmentioning
confidence: 99%
“…Our protocol of directed multilineage differentiation assay for human adult NCSCs was described earlier in details [45]. Briefly, we used the following differentiation media and adhesive substrates: adipogenic differentiation medium: DMEM high glucose (4.5 g/l) (BioWest, France) supplemented with 10% FBS, 1 μ M dexamethasone, 50 μ M indomethacine, 250 μ M isobutylmethylxanthine, 5 μ g/ml insulin (all: Sigma-Aldrich, USA), and 5% horse serum (BioWest, France); osteogenic differentiation medium: DMEM low glucose (1.0 g/l) (BioWest, France) supplemented with 10% FBS, 100 nM dexamethasone, 10 mM β -glycerophosphate, and 50 μ g/ml ascorbate-2-phosphate (all: Sigma-Aldrich, USA); neuronal differentiation medium: neurobasal medium (Gibco, UK), 2% B27 supplement (Gibco, UK), 1% N2 supplement (Gibco, UK), 5 μ M ec32 synthetic retinoid (AMSBIO, UK), 1 μ M forskolin (Sigma-Aldrich, USA), 20 ng/ml NGF (PeproTech, USA), 20 ng/ml BDNF (PeproTech, USA), 20 ng/ml GDNF (PeproTech, USA), and 20 ng/ml IGF (Gibco, UK); glial differentiation medium: neurobasal (Gibco, UK) and DMEM:F12 (Gibco, UK) media in a ratio 1 : 1, 2% B27 supplement (Gibco, UK), 1% N2 supplement (Gibco, UK), 1 μ M ec32 synthetic retinoid (AMSBIO, UK), 5 μ M forskolin (Sigma-Aldrich, USA), 20 ng/ml Neuregulin-1 (Gibco, UK), 10 ng/ml PDGF-BB (PeproTech, USA), and 20 ng/ml IGF (Gibco, UK).…”
Section: Methodsmentioning
confidence: 99%
See 3 more Smart Citations